Cancer Therapy : Preclinical FKBPL and Peptide Derivatives : Novel Biological Agents That Inhibit Angiogenesis by a CD 44-Dependent Mechanism
暂无分享,去创建一个
D. Hirst | H. McCarthy | D. Waugh | R. Bicknell | T. Robson | T. Harrison | J. Worthington | M. O’Rourke | A. Yakkundi | H. McKeen | Michelle B. Hookham | G. Cotton | A. Valentine | K. McClelland | L. McCallum | H. Dyer | Jennifer Roberts | Joanne Mcgregor | I. James | Hayley D. McKeen | Keeva McClelland